RESEARCH-USE BIOSIMILAR ANTIBODY
Exidavnemab
Monoclonal antibody · IgG4 kappa
Exidavnemab is a chimeric and/or humanised biosimilar reference antibody directed against SNCA.
TARGETSNCA
YMonoclonal antibody
CATALOGSC-BS-553
CATALOG NUMBERSC-BS-553
MOLECULAR WEIGHTApprox. 145 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Exidavnemab is a chimeric and/or humanised biosimilar reference antibody directed against SNCA.
Exidavnemab is a recombinant research-use antibody directed against SNCA.